Skip to main content
. 2014 Jul 8;9(7):e101969. doi: 10.1371/journal.pone.0101969

Table 1. Pyrvinium treated CRC cell lines: summary.

CRC Cells MTT Assay IC50 (nM) Clonogenic Assay IC50 (nM) P53 Mutations Oncogenes Expressed
HT29 135 10 G>A (Arg->His) 273 MYC, RAS, MYB, FOS
SW480 47 13 G>A (Arg->His) 273/C>T (Pro->Ser) 309 MYC, RAS, MYB, FOS
SW620 513 54 G>A (Arg->His) 273 MYC, RAS, MYB, FOS
HCT116 87 8 WT p53, p21 deficient MYC, RAS, MYB